查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2102333

神經多樣性評估平台市場：預測至 2034 年—按平台類型、評估類型、部署模式、定價模式、最終用戶和地區分類的全球分析

Neurodiversity Assessment Platforms Market Forecasts to 2034 - Global Analysis By Platform Type, Assessment Type, Deployment Mode, Pricing Model, End User, and Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球神經多樣性評估平台市場預計將在 2026 年達到 23 億美元，並在預測期內以 18.3% 的複合年成長率成長，到 2034 年達到 88 億美元。

神經多樣性評估平台是能夠幫助篩檢、評估和識別各種認知特徵的數位化工具，包括自閉症、注意力不足過動症（ADHD）、閱讀障礙、運動障礙和其他神經發育差異。這些平台利用標準化評估、人工智慧、行為分析和數位化問卷，幫助醫療保健專業人員、教育工作者、雇主和個人了解自身的認知優勢和支持需求。它們還有助於早期發現問題、制定個人化干預計劃，並在職場和教育環境中實施合理的調整措施。人們對神經多樣性的認知不斷提高，對便利評估的需求日益成長，以及數位健康技術的進步，正在推動神經多樣性評估平台在全球範圍內的普及應用。

數位篩檢的廣泛應用

神經多樣性評估平台提供數位化工具，透過標準化的實證評估方法，幫助識別、評估和監測不同的認知特徵。醫療保健專業人員、教育機構和雇主正擴大採用數位化評估，以提高評估的可及性並簡化評估流程。人們對早期發現和個人化支持策略的日益重視正在推動市場需求。技術創新正在提高評估的準確性、使用者體驗和報告功能。數位化轉型使神經多樣性評估在各種環境中都更加便利。技術驅動的評估正在重塑神經多樣性識別和支持的未來。

訓練有素的專業人員短缺

合格的專業人員對於解讀評估結果、提供臨床指導和製定適當的支持措施至關重要。專業人員數量有限會導致評估延遲或無法及時進行評估。在許多地區，醫療保健和教育系統仍然面臨人才短缺的問題。技術開發人員正在開發輔助專業人員的決策支援功能，而不是取代臨床專業知識。持續的培訓計畫正在提升專業人員的能力。專業人員的可用性仍然影響著平台的有效使用。

人工智慧驅動的評估技術

人工智慧透過分析行為模式、產生個人化見解並支援更一致的評估流程，從而提高評估效率。智慧演算法利用結構化資料和數位互動來幫助識別認知特徵。自動化分析提高了報告質量，同時減輕了專家的行政負擔。機器學習的不斷進步正在提高評估的準確性和適應性。人工智慧的整合擴展了數位神經多樣性評估的擴充性。人工智慧正在為個人化和高效的評估解決方案開闢新的可能性。

對評估工具的監管

數位評估平台必須展現臨床有效性、資料安全性、透明度，並符合​​不斷變化的醫療和教育法規。監管要求可能會增加解決方案供應商的開發時間和合規成本。各機構必須在整個產品開發過程中保持嚴格的品質標準。持續的檢驗研究能夠提高評估結果的可靠性。適應不斷變化的監管預期仍然是該行業的首要任務。強大的監管合規性對於維護長期的市場信譽至關重要。

新型冠狀病毒（COVID-19）的影響：

新冠疫情加速了數位化評估技術的應用，遠端醫療、教育和職場服務的重要性日益凸顯。虛擬評估平台使專業人員能夠在面對面交流受限期間繼續進行神經多樣性評估，同時降低服務取得障礙。醫療保健和教育機構對遠距篩檢和數位化輔助工具的需求不斷成長。各機構紛紛投資技術，以提高服務的可近性和連續性。這些經驗增強了人們對數位化評估模式的信心。疫情後的數位轉型將持續推動市場持續成長。

在預測期內，自閉症評估領域預計將佔據最大的市場佔有率。

在預測期內，自閉症評估領域預計將佔據最大的市場佔有率，這主要得益於公眾意識的提高、早期療育工作的開展以及對便捷診斷支持需求的成長。醫療機構和教育機構正持續擴大兒童和成人的篩檢計畫。數位化平台提高了評估的一致性和報告效率。循證評估方法的進步進一步推動了其應用。人們對早期檢測益處的認知不斷提高，也鞏固了其市場領先地位。自閉症評估仍然是數位化神經多樣性評估的主要應用領域之一。

預計在預測期內，公司板塊將呈現最高的複合年成長率。

在預測期內，企業市場預計將呈現最高的成長率，這主要得益於神經多樣性評估平台在支援包容性招募、職場發展、員工培訓和員工福祉計畫方面的日益普及。各組織體認到了解員工多樣化認知優勢的價值。數位化評估工具有助於制定更個人化的員工支援策略。企業不斷擴展的多元化措施持續推動著科技的應用。人力資源部門的現代化進一步加速了企業環境中的普及。預計企業應用將成為未來市場成長的主要驅動力。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其在行為健康技術領域的大力投資以及技術驅動型評估解決方案的廣泛應用。醫療機構和教育機構正持續擴大其對數位化評估平台的利用。研究機構也積極致力於創新和臨床檢驗。有利於技術應用的良好環境促進了新解決方案的快速商業化。強大的機構投資正在鞏固該地區的領先地位。北美將繼續引領神經多樣性評估技術的發展。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於新興經濟體對教育科技投資的增加以及基於技術的評估服務可及性的提升。各國政府和私營機構正在加大對早期療育和心理健康領域的投入。對便捷評估解決方案日益成長的需求持續推動市場擴張。快速的數位轉型正在提升全部區域服務的可及性。對醫療保健技術的持續投資正在創造長期機會。亞太地區可望成為神經多樣性評估平台成長最快的市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球神經多樣性評估平台市場：依平台類型分類

  • 認知評估平台
  • 行為評估平台
  • 技能評估平台
  • 職場評估平台
  • 教育評估平台
  • 其他平台類型

第6章：全球神經多樣性評估平台市場：依評估類型分類

  • 自閉症評估
  • 注意力不足過動症評估
  • 學習障礙評估
  • 認知能力評估
  • 行為評估
  • 其他評估類型

第7章 全球神經多樣性評估平台市場：依部署模式分類

  • 基於雲端的
  • 現場

第8章：全球神經多樣性評估平台市場：依定價模式

  • 基於訂閱
  • 一次許可證
  • 基於使用情況
  • 免費增值
  • 其他定價模式

第9章 全球神經多樣性評估平台市場：依最終用戶分類

  • 醫療服務提供方
  • 教育機構
  • 公司組織
  • 研究機構
  • 政府機構
  • 其他最終用戶

第10章：全球神經多樣性評估平台市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Pearson plc
  • Hogrefe AG
  • Cambridge Cognition Ltd.
  • Cogstate Ltd.
  • Psychology Software Tools, Inc.
  • CNS Vital Signs
  • MedAvante-ProPhase Inc.
  • Prometric LLC
  • Q-interactive
  • Microsoft Corporation
  • IBM Corporation
  • Oracle Corporation
  • SAP SE
  • Google LLC
  • Workday, Inc.
Product Code: SMRC38324

According to Stratistics MRC, the Global Neurodiversity Assessment Platforms Market is accounted for $2.3 billion in 2026 and is expected to reach $8.8 billion by 2034 growing at a CAGR of 18.3% during the forecast period. Neurodiversity assessment platforms are digital tools that support the screening, evaluation, and identification of diverse cognitive profiles, including autism, ADHD, dyslexia, dyspraxia, and other neurodevelopmental differences. These platforms utilize standardized assessments, artificial intelligence, behavioral analytics, and digital questionnaires to assist healthcare providers, educators, employers, and individuals in understanding cognitive strengths and support needs. They facilitate early identification, personalized intervention planning, and workplace or educational accommodations. Growing awareness of neurodiversity, increased demand for accessible assessments, and advancements in digital health technologies are driving the adoption of neurodiversity assessment platforms worldwide.

Market Dynamics:

Driver:

Growing adoption of digital screening

Neurodiversity assessment platforms provide digital tools that support the identification evaluation and monitoring of diverse cognitive profiles through standardized evidence-based assessment methods. Healthcare providers educational institutions and employers are increasingly adopting digital assessments to improve accessibility and streamline evaluation processes. Growing awareness of early identification and personalized support strategies is strengthening market demand. Technological innovation is enhancing assessment accuracy user experience and reporting capabilities. Digital transformation is making neurodiversity evaluations more accessible across multiple settings. Technology-enabled assessments are reshaping the future of neurodiversity identification and support.

Restraint:

Shortage of trained specialists

Qualified professionals are essential for interpreting assessment results providing clinical guidance and developing appropriate support recommendations. Limited specialist availability can delay assessments and reduce access to timely evaluations. Healthcare and educational systems continue facing workforce shortages in many regions. Technology developers are creating decision support features that assist professionals without replacing clinical expertise. Ongoing training initiatives are helping expand professional capabilities. Specialist availability continues to influence effective platform utilization.

Opportunity:

AI-assisted assessment technologies

Artificial intelligence improves assessment efficiency by analyzing behavioral patterns generating personalized insights and supporting more consistent evaluation processes. Intelligent algorithms help identify cognitive characteristics using structured data and digital interactions. Automated analysis enhances reporting while reducing administrative workload for professionals. Continuous advancements in machine learning are improving assessment precision and adaptability. AI integration is expanding the scalability of digital neurodiversity evaluations. Artificial intelligence is opening new possibilities for personalized and efficient assessment solutions.

Threat:

Regulatory scrutiny of assessment tools

Digital assessment platforms must demonstrate clinical validity data security transparency and compliance with evolving healthcare and educational regulations. Regulatory requirements may increase development timelines and compliance costs for solution providers. Organizations must maintain rigorous quality standards throughout product development. Continuous validation studies strengthen confidence in assessment outcomes. Adapting to changing regulatory expectations remains an ongoing industry priority. Strong regulatory compliance is essential for maintaining long-term market credibility.

Covid-19 Impact:

The COVID-19 pandemic accelerated the adoption of digital assessment technologies as remote healthcare education and workplace services became increasingly important. Virtual assessment platforms enabled professionals to continue neurodiversity evaluations while reducing barriers to access during periods of restricted in-person interaction. Demand for remote screening and digital support tools increased across healthcare and educational settings. Organizations invested in technology to improve accessibility and service continuity. The experience strengthened confidence in digital assessment models. Post-pandemic digital transformation continues supporting sustained market expansion.

The autism assessment segment is expected to be the largest during the forecast period

The autism assessment segment is expected to account for the largest market share during the forecast period due to increasing awareness early intervention initiatives and growing demand for accessible diagnostic support. Healthcare providers and educational institutions continue expanding screening programs for children and adults. Digital platforms improve assessment consistency and reporting efficiency. Advances in evidence-based assessment methods further strengthen adoption. Growing recognition of early identification benefits supports continued market leadership. Autism assessment remains the primary application within digital neurodiversity evaluation.

The corporate organizations segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the corporate organizations segment is predicted to witness the highest growth rate due to increasingly adopting neurodiversity assessment platforms to support inclusive hiring workplace accommodations employee development and workforce well-being initiatives. Organizations recognize the value of understanding diverse cognitive strengths within their workforce. Digital assessment tools help create more personalized employee support strategies. Growing corporate diversity commitments continue encouraging technology adoption. Human resource modernization further accelerates implementation across enterprise environments. Corporate adoption is expected to become a major driver of future market growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to strong investment in behavioral health technologies and widespread adoption of technology-enabled assessment solutions. Healthcare providers and educational institutions continue expanding access to digital evaluation platforms. Research organizations actively contribute to innovation and clinical validation. Favorable technology adoption supports rapid commercialization of new solutions. Strong institutional investment reinforces regional leadership. North America continues to lead the advancement of neurodiversity assessment technologies.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by growing educational technology investments and improving access to technology-based assessment services across emerging economies. Governments and private organizations are strengthening early intervention and mental health initiatives. Rising demand for accessible assessment solutions continues supporting market expansion. Rapid digital transformation is improving service availability throughout the region. Continuous investment in healthcare technology creates favorable long-term opportunities. Asia Pacific is expected to emerge as the fastest-growing market for neurodiversity assessment platforms.

Key players in the market

Some of the key players in Neurodiversity Assessment Platforms Market include Pearson plc, Hogrefe AG, Cambridge Cognition Ltd., Cogstate Ltd., Psychology Software Tools, Inc., CNS Vital Signs, MedAvante-ProPhase Inc., Prometric LLC, Q-interactive, Microsoft Corporation, IBM Corporation, Oracle Corporation, SAP SE, Google LLC, Workday, Inc.

Key Developments:

In September 2025, Neuralink received FDA Breakthrough Device Designation for its speech restoration technology, accelerating clinical trials for its implantable brain-computer interface targeting severe vocal and motor impairments to restore natural communication protocols for patients.

In August 2025, Microsoft Corporation embedded predictive machine learning filters natively into the Windows and Xbox accessibility software layers to suppress high-frequency visual flashes and sudden audio transients automatically. These automated display adjustments prevent rapid neural fatigue and lower the risk of sensory overload for gamers with photosensitive neurological profiles.

Platform Types Covered:

  • Cognitive Assessment Platforms
  • Behavioral Assessment Platforms
  • Skills Assessment Platforms
  • Workplace Assessment Platforms
  • Educational Assessment Platforms
  • Other Platform Types

Assessment Types Covered:

  • Autism Assessment
  • ADHD Assessment
  • Learning Disability Assessment
  • Cognitive Ability Assessment
  • Behavioral Assessment
  • Other Assessment Types

Deployment Modes Covered:

  • Cloud-Based
  • On-Premises

Pricing Models Covered:

  • Subscription-Based
  • One-Time License
  • Usage-Based
  • Freemium
  • Other Pricing Models

End Users Covered:

  • Healthcare Providers
  • Educational Institutions
  • Corporate Organizations
  • Research Institutes
  • Government Organizations
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Neurodiversity Assessment Platforms Market, By Platform Type

  • 5.1 Cognitive Assessment Platforms
  • 5.2 Behavioral Assessment Platforms
  • 5.3 Skills Assessment Platforms
  • 5.4 Workplace Assessment Platforms
  • 5.5 Educational Assessment Platforms
  • 5.6 Other Platform Types

6 Global Neurodiversity Assessment Platforms Market, By Assessment Type

  • 6.1 Autism Assessment
  • 6.2 ADHD Assessment
  • 6.3 Learning Disability Assessment
  • 6.4 Cognitive Ability Assessment
  • 6.5 Behavioral Assessment
  • 6.6 Other Assessment Types

7 Global Neurodiversity Assessment Platforms Market, By Deployment Mode

  • 7.1 Cloud-Based
  • 7.2 On-Premises

8 Global Neurodiversity Assessment Platforms Market, By Pricing Model

  • 8.1 Subscription-Based
  • 8.2 One-Time License
  • 8.3 Usage-Based
  • 8.4 Freemium
  • 8.5 Other Pricing Models

9 Global Neurodiversity Assessment Platforms Market, By End User

  • 9.1 Healthcare Providers
  • 9.2 Educational Institutions
  • 9.3 Corporate Organizations
  • 9.4 Research Institutes
  • 9.5 Government Organizations
  • 9.6 Other End Users

10 Global Neurodiversity Assessment Platforms Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Pearson plc
  • 13.2 Hogrefe AG
  • 13.3 Cambridge Cognition Ltd.
  • 13.4 Cogstate Ltd.
  • 13.5 Psychology Software Tools, Inc.
  • 13.6 CNS Vital Signs
  • 13.7 MedAvante-ProPhase Inc.
  • 13.8 Prometric LLC
  • 13.9 Q-interactive
  • 13.10 Microsoft Corporation
  • 13.11 IBM Corporation
  • 13.12 Oracle Corporation
  • 13.13 SAP SE
  • 13.14 Google LLC
  • 13.15 Workday, Inc.

List of Tables

  • Table 1 Global Neurodiversity Assessment Platforms Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Neurodiversity Assessment Platforms Market, By Platform Type (2023-2034) ($MN)
  • Table 3 Global Neurodiversity Assessment Platforms Market, By Cognitive Assessment Platforms (2023-2034) ($MN)
  • Table 4 Global Neurodiversity Assessment Platforms Market, By Behavioral Assessment Platforms (2023-2034) ($MN)
  • Table 5 Global Neurodiversity Assessment Platforms Market, By Skills Assessment Platforms (2023-2034) ($MN)
  • Table 6 Global Neurodiversity Assessment Platforms Market, By Workplace Assessment Platforms (2023-2034) ($MN)
  • Table 7 Global Neurodiversity Assessment Platforms Market, By Educational Assessment Platforms (2023-2034) ($MN)
  • Table 8 Global Neurodiversity Assessment Platforms Market, By Other Platform Types (2023-2034) ($MN)
  • Table 9 Global Neurodiversity Assessment Platforms Market, By Assessment Type (2023-2034) ($MN)
  • Table 10 Global Neurodiversity Assessment Platforms Market, By Autism Assessment (2023-2034) ($MN)
  • Table 11 Global Neurodiversity Assessment Platforms Market, By ADHD Assessment (2023-2034) ($MN)
  • Table 12 Global Neurodiversity Assessment Platforms Market, By Learning Disability Assessment (2023-2034) ($MN)
  • Table 13 Global Neurodiversity Assessment Platforms Market, By Cognitive Ability Assessment (2023-2034) ($MN)
  • Table 14 Global Neurodiversity Assessment Platforms Market, By Behavioral Assessment (2023-2034) ($MN)
  • Table 15 Global Neurodiversity Assessment Platforms Market, By Other Assessment Types (2023-2034) ($MN)
  • Table 16 Global Neurodiversity Assessment Platforms Market, By Deployment Mode (2023-2034) ($MN)
  • Table 17 Global Neurodiversity Assessment Platforms Market, By Cloud-Based (2023-2034) ($MN)
  • Table 18 Global Neurodiversity Assessment Platforms Market, By On-Premises (2023-2034) ($MN)
  • Table 19 Global Neurodiversity Assessment Platforms Market, By Pricing Model (2023-2034) ($MN)
  • Table 20 Global Neurodiversity Assessment Platforms Market, By Subscription-Based (2023-2034) ($MN)
  • Table 21 Global Neurodiversity Assessment Platforms Market, By One-Time License (2023-2034) ($MN)
  • Table 22 Global Neurodiversity Assessment Platforms Market, By Usage-Based (2023-2034) ($MN)
  • Table 23 Global Neurodiversity Assessment Platforms Market, By Freemium (2023-2034) ($MN)
  • Table 24 Global Neurodiversity Assessment Platforms Market, By Other Pricing Models (2023-2034) ($MN)
  • Table 25 Global Neurodiversity Assessment Platforms Market, By End User (2023-2034) ($MN)
  • Table 26 Global Neurodiversity Assessment Platforms Market, By Healthcare Providers (2023-2034) ($MN)
  • Table 27 Global Neurodiversity Assessment Platforms Market, By Educational Institutions (2023-2034) ($MN)
  • Table 28 Global Neurodiversity Assessment Platforms Market, By Corporate Organizations (2023-2034) ($MN)
  • Table 29 Global Neurodiversity Assessment Platforms Market, By Research Institutes (2023-2034) ($MN)
  • Table 30 Global Neurodiversity Assessment Platforms Market, By Government Organizations (2023-2034) ($MN)
  • Table 31 Global Neurodiversity Assessment Platforms Market, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.